Immutrin is a biotechnology company developing next generation antibody therapy to deplete systemic amyloid deposits and reverse amyloidosis.
Investors 1
| Date | Name | Website |
| 21.04.2026 | Cambridge ... | cic.vc |
Mentions in press and media 1
| Date | Title | Description |
| - | Immutrin | “Immutrin is a biotechnology company developing next generation antibody therapy to deplete systemic amyloid deposits and reverse amyloidosis.” |